Capmatinib Recruiting Phase 2 Trials for Malignant Non-small Cell Neoplasm of Lung Stage IV Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02750215A Study of Capmatinib (INC280) in NSCLC Patients With MET Exon 14 Alterations Who Have Received Prior MET Inhibitor